Ben Thompson, ARVO 2021: Enhancement of Visual Cortex Neuroplasticity in Adults with Amblyopia
We spoke with Ben Thompson (University of Waterloo, Waterloo, ON, Canada) about neuroplasticity, and the relevance of visual plasticity in the treatment of amblyopia.
Questions
- Could you give us a brief overview of neuroplasticity and its biological basis? (00:13)
- What manifestations of visual plasticity exist in the visual cortex of adults? (01:11)
- What is the relevance of visual plasticity in the treatment of amblyopia? (02:09)
Speaker Disclosure: Ben Thompson discloses the following: Two patents relating to binocular amblyopia treatment that have been licensed by Novartis. Two patents relating to assessment of children’s vision and co-founder of Objective Acuity, a company commercializing this technology. Paid consultancy for Novartis and Objective Acuity.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.
Filmed in coverage of ARVO 2021.